- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05432869
Effects of External Electrical Stimulating Applied on the Thigh in Men With Urinary Incontinence After Prostatectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The most common complication after prostatectomy surgeries is urinary incontinence. There are conservative and surgical treatment options in post-prostatectomy urinary incontinence. One of the conservative treatment options is electrical stimulation application.
Electrical stimulation with the intraanal probe in men is painful and uncomfortable.
And also there are few studies, demonstrating the effects of electrical stimulation on urinary incontinence after prostatectomy in the literature.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being a male individual with stress or stress-dominant mixed urinary incontinence symptoms after undergoing prostatectomy surgery
- Being over 40 years old
- Not having residual cancerous tissue
- Volunteering to participate in the study
Exclusion Criteria:
- Having serious cardiovascular disease (unstable angina and arrhythmia patients, heart failure patients, etc.)
- Having sensory loss
- Having an ongoing urinary infection
- Having only urgency urinary incontinence
- Using a pacemaker
- Receiving active cancer treatment (radiotherapy, chemotherapy)
- Those who have a problem that interferes with cooperation and understanding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Electrical stimulation (ES) group
ES group will be given additional external electrical stimulation to the lifestyle advices.
|
The lifestyle advices include fluid consumption, diet, weight control, constipation, smoking, etc. External electrical stimulation will be applied for 30 minutes 3 days a week during 4 weeks. Electrodes were placed on the thighs. |
|
Experimental: Control group
Control group will be given only lifestyle advices .
|
The lifestyle advices include fluid consumption, diet, weight control, constipation, smoking, etc.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urinary incontinence severity
Time Frame: change from baseline at 4 weeks
|
Urinary incontinence severity will be assessed with a 1-hour pad test.
This amount; less than 2 grams is considered normal, 2-10 grams is mild, 10-50 grams is moderate, and over 50 grams is severe stress urinary incontinence.
|
change from baseline at 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of urinary incontinence symptoms
Time Frame: change from baseline at 4 weeks
|
Urinary incontinence symptoms will be assessed with International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF).
It consists of 6 questions in total and the total score is 3., 4., 5.
It is obtained by adding the scores they get from the questions.
A low score in the scale indicates that urinary incontinence symptoms are less.
|
change from baseline at 4 weeks
|
|
Life quality
Time Frame: change from baseline at 4 weeks
|
Life quality will be assessed with King Health Questionnaire.
The questionnaire, consisting of thirty-two items, consists of 2 parts.
In the first part, there are 2 questions questioning the general health perception and incontinence effect, and 19 questions dividing the quality of life into 7 areas (role limitations, physical limitations, social limitations, personal relationships, emotional problems, sleep/energy disorders, symptom severity measurement).
In the second part, there are 11-item complaint severity scales that evaluate the presence and severity of urinary symptoms.
While the best score that can be obtained on the complaint severity scale is "0", the worst score is "30", the best score that can be obtained for all King Health Questionnaire subsections is "0" and the worst score is "100".
|
change from baseline at 4 weeks
|
|
Sexual function
Time Frame: change from baseline at 4 weeks
|
Sexual function will be assessed with International Index of Erectile Function-5.
It includes 5 main topics; erectile function, orgasm function, sexual desire, sexual intercourse satisfaction and general satisfaction are questioned with a total of 5 questions.
Each question gets a score between 0-5.
Total score; severe (5-7), moderate (8-11), mild-moderate (12-16), mild (17-21), no erectile dysfunction (22-25)
|
change from baseline at 4 weeks
|
|
Perception of Subjective Improvement
Time Frame: after treatment (4th week)
|
Patients' subjective perception of improvement will be questioned with a 4-point Likert scale (worse (1), same (2), better (3) and completely cured (4))
|
after treatment (4th week)
|
|
Patients Satisfaction
Time Frame: after treatment (4th week)
|
Patient satisfaction will be questioned with a 5-point Likert scale (not at all satisfied (1), dissatisfied (2), undecided (3), satisfied (4), very satisfied (5))
|
after treatment (4th week)
|
|
Compliance with Lifestyle Advices
Time Frame: after treatment (4th week)
|
Compliance of patients to the lifestyle advices will be evaluated using a 100-mm visual analog scale.
|
after treatment (4th week)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/06/22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
Clinical Trials on ES and lifestyle advices
-
University of ReadingCompletedDiabetes, Type 2 | Diabetes Mellitus, Noninsulin-DependentUnited Kingdom, Kuwait
-
Rennes University HospitalMinistry of Health, FranceCompletedLiver Cirrhosis | Iron OverloadFrance
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Cairo UniversityCompleted
-
Cairo UniversityCompletedPrimary DysmenorrheaEgypt
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityRecruiting
-
Instituto Nacional de Cancerologia, ColumbiaUniversidad de CartagenaCompletedTeenager | Health AdultsColombia
-
Institut Claudius RegaudCompleted
-
University of OuluEnrolling by invitation